3D Spheroidal Culture for Mesenchymal Stem Cell Differentiation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for differentiating pluripotent stem cells into mesenchymal stem cells are inefficient, time-consuming, and face challenges with cell senescence and high costs, particularly due to reliance on 2D adherent culturing and the difficulties in amplifying mesenchymal stem cells from adult tissues.
Innovation Solution
A method involving 3D suspension culturing using BMP4 and A8301 to differentiate pluripotent stem cells into trophoblast-like cells, followed by mesenchymal stem cells, with no need for passaging or culture container replacement, utilizing a specific culture medium that includes DMEM low-sugar medium, serum substitute, and non-essential amino acids to enhance proliferation and anti-apoptotic ability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If 2D adherent culturing is used to differentiate pluripotent stem cells into mesenchymal stem cells, then the differentiation process can be performed, but the efficiency is low and the process requires 3-5 procedures with multiple passaging and flask changes
Solution Approach 1:
The patent transitions from 2D adherent culturing to 3D suspension culturing, fundamentally changing the dimensional space in which cells are cultured. This dimensional shift enables cells to form spheroids that can be amplified and differentiated in a single continuous process without requiring multiple passaging steps or flask changes, thereby dramatically improving differentiation efficiency and reducing time loss
2Quantity of substance
If mesenchymal stem cells are isolated from adult tissues, then they can be obtained, but the collection process is time-consuming, costly, and the cells are difficult to amplify in large amounts
Solution Approach 1:
The patent performs preliminary amplification of pluripotent stem cells in 3D suspension culture before differentiation into mesenchymal stem cells. This preliminary expansion step allows generation of sufficient cell quantities in advance, eliminating the need for time-consuming and costly isolation from adult tissues later, and enabling large-scale production of differentiated cells
3Reliability
If multiple passaging and flask changes are performed during differentiation, then cell culture can be maintained, but the costs increase and the process becomes more complex
Solution Approach 1:
The patent combines amplification and differentiation processes into a single integrated 3D suspension culture system. Cell clusters are formed once and maintained throughout the entire differentiation process without requiring separation into multiple culture vessels or repeated passaging, thereby maintaining culture reliability while dramatically reducing process complexity
Data Source
AI summary
A method of differentiating pluripotent stem cells into mesenchymal stem cells, a culture medium used in the method of differentiating pluripotent stem cells into mesenchymal stem cells and a method of performing tissue and organ regeneration by using the mesenchymal stem cells obtained by differentiation using the method of differentiating pluripotent stem cells into mesenchymal stem cells are provided. The method of differentiating pluripotent stem cells into mesenchymal stem cells comprises differentiating, completely under 3D suspension conditions, pluripotent stem cells into trophoblast-like cells using BMP4 and A8301, and then differentiating the trophoblast-like cells into mesenchymal stem cells. Neither of two differentiation processes needs passaging or replacement of a culture container.